博腾股份2月25日获融资买入1466.35万元,融资余额3.43亿元

Core Viewpoint - Boten Co., Ltd. has shown a mixed performance in financing activities and stockholder dynamics, with significant growth in revenue and net profit year-on-year, indicating potential investment opportunities in the pharmaceutical sector [1][2]. Financing Activities - On February 25, Boten Co., Ltd. recorded a financing buy-in amount of 14.66 million yuan, with a net financing outflow of 434,100 yuan, resulting in a total financing balance of 343 million yuan, which constitutes 2.68% of its market capitalization [1]. - The financing balance is below the 10% percentile level over the past year, indicating a low level of financing activity [1]. - In terms of securities lending, there were no shares sold or repaid on February 25, with a remaining short position of 13,400 shares and a balance of 316,200 yuan, also below the 20% percentile level over the past year [1]. Company Performance - As of February 13, the number of shareholders for Boten Co., Ltd. was 42,100, a decrease of 0.68%, while the average circulating shares per person increased by 0.68% to 11,843 shares [2]. - For the period from January to September 2025, Boten Co., Ltd. achieved a revenue of 2.544 billion yuan, representing a year-on-year growth of 19.72%, and a net profit attributable to shareholders of 79.92 million yuan, which is a significant increase of 138.71% year-on-year [2]. Dividend and Shareholder Structure - Since its A-share listing, Boten Co., Ltd. has distributed a total of 1.193 billion yuan in dividends, with 866 million yuan distributed over the past three years [3]. - As of September 30, 2025, the top ten circulating shareholders included Hong Kong Central Clearing Limited as the fourth largest shareholder with 23.98 million shares, an increase of 13.22 million shares from the previous period [3]. - Tianhong Medical Innovation A ranked as the sixth largest shareholder with 5.94 million shares, a decrease of 458,400 shares, while Huazheng Select Mixed Fund entered as the ninth largest shareholder with 3.78 million shares [3].

Porton-博腾股份2月25日获融资买入1466.35万元,融资余额3.43亿元 - Reportify